| scholarly article | Q13442814 |
| P2093 | author name string | Qiang Wu | |
| Paul A Lapchak | |||
| P2860 | cites work | Haemostatic drug therapies for acute primary intracerebral haemorrhage | Q24245531 |
| Preclinical and clinical research on inflammation after intracerebral hemorrhage | Q24594191 | ||
| Neuroprotection for ischemic stroke: past, present and future | Q24645185 | ||
| Pathobiology of ischaemic stroke: an integrated view | Q28141682 | ||
| Inflammation and infection in clinical stroke | Q28194382 | ||
| Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage | Q28242554 | ||
| Stroke | Q28279570 | ||
| Subarachnoid haemorrhage | Q28285437 | ||
| Heme oxygenase 2 is neuroprotective against intracerebral hemorrhage | Q28295659 | ||
| Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q28303699 | ||
| Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1 | Q28371872 | ||
| Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases | Q28580357 | ||
| How matrix metalloproteinases regulate cell behavior | Q29620360 | ||
| S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death | Q30843579 | ||
| Free radicals as triggers of brain edema formation after stroke. | Q30990948 | ||
| The cytosolic antioxidant, copper/zinc superoxide dismutase, attenuates blood-brain barrier disruption and oxidative cellular injury after photothrombotic cortical ischemia in mice | Q31005899 | ||
| Neuroprotective effect of hyperbaric oxygen in a rat model of subarachnoid hemorrhage. | Q33242054 | ||
| Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats | Q33418203 | ||
| Hyperbaric oxygen therapy and cerebral ischemia: neuroprotective mechanisms | Q33419743 | ||
| Combination therapy with normobaric oxygen (NBO) plus thrombolysis in experimental ischemic stroke | Q33482531 | ||
| Inflammatory mediators and stroke: new opportunities for novel therapeutics | Q33718239 | ||
| Structure-activity relationship of hydroxamate-based inhibitors on membrane-bound Fas ligand and TNF-alpha processing. | Q33759110 | ||
| Antioxidants, oxidative stress, and degenerative neurological disorders | Q33796840 | ||
| Matrix metalloproteinases: biologic activity and clinical implications | Q33849967 | ||
| Signal transduction by protease-activated receptors | Q33870369 | ||
| Brain ischemia and reperfusion: molecular mechanisms of neuronal injury | Q33923323 | ||
| Resolving the negative data publication dilemma in translational stroke research | Q33930564 | ||
| A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? | Q33938450 | ||
| Blood-brain barrier breakdown and repair by Src after thrombin-induced injury | Q34056846 | ||
| Course, management and outcome of oral-anticoagulant-related intracranial haemorrhages | Q34075227 | ||
| New approaches to neuroprotective drug development | Q34155324 | ||
| Hydrogen gas reduced acute hyperglycemia-enhanced hemorrhagic transformation in a focal ischemia rat model. | Q41860346 | ||
| Thrombin inhibition by argatroban ameliorates early brain injury and improves neurological outcomes after experimental subarachnoid hemorrhage in rats | Q42016943 | ||
| Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products | Q42170839 | ||
| Effect of delayed mild brain hypothermia on edema formation after intracerebral hemorrhage in rats. | Q42438020 | ||
| Microglial activation and brain injury after intracerebral hemorrhage | Q42446172 | ||
| Iron and iron-handling proteins in the brain after intracerebral hemorrhage. | Q42452709 | ||
| Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size | Q42455530 | ||
| Collagenase-induced intracerebral hemorrhage in rats | Q42479802 | ||
| Systemic complement depletion diminishes perihematomal brain edema in rats | Q42497904 | ||
| Absence of early proinflammatory cytokine expression in experimental intracerebral hemorrhage | Q42508600 | ||
| Regulation of matrix metalloproteinases and effect of MMP-inhibition in heart transplant related reperfusion injury | Q42523333 | ||
| Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model | Q42528909 | ||
| High dose baclofen is neuroprotective but also causes intracerebral hemorrhage: a quantal bioassay study using the intraluminal suture occlusion method | Q42546997 | ||
| Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. | Q42550130 | ||
| Thrombin mediates severe neurovascular injury during ischemia | Q42938975 | ||
| Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits | Q43571481 | ||
| Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis | Q43719854 | ||
| Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice | Q43722033 | ||
| Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction | Q43800025 | ||
| The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke | Q43847077 | ||
| Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator | Q44019972 | ||
| Delayed argatroban treatment reduces edema in a rat model of intracerebral hemorrhage | Q44240532 | ||
| Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters | Q44418044 | ||
| Therapeutic hypothermia in acute ischemic stroke | Q44502574 | ||
| Batimastat reduces Mycobacterium tuberculosis-induced apoptosis in macrophages. | Q44614844 | ||
| Effect of delayed argatroban treatment on intracerebral hemorrhage-induced edema in the rat. | Q44749645 | ||
| Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage | Q44834390 | ||
| Heme oxygenase in experimental intracerebral hemorrhage: the benefit of tin-mesoporphyrin | Q44951302 | ||
| Different degrees of hypothermia after experimental stroke: short- and long-term outcome | Q45112055 | ||
| Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice | Q45141100 | ||
| Holo-transferrin and thrombin can interact to cause brain damage | Q45214943 | ||
| The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia. | Q45253597 | ||
| Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. | Q45993411 | ||
| Simvastatin attenuates cerebral vasospasm and improves outcomes by upregulation of PI3K/Akt pathway in a rat model of subarachnoid hemorrhage. | Q46039600 | ||
| Brain genomics of intracerebral hemorrhage | Q46221974 | ||
| SOD1 down-regulates NF-kappaB and c-Myc expression in mice after transient focal cerebral ischemia | Q46256462 | ||
| Tumor necrosis factor-alpha is involved in thrombolytic-induced hemorrhage following embolic strokes in rabbits | Q46279950 | ||
| Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha | Q46370124 | ||
| 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats | Q46738559 | ||
| Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage | Q46838344 | ||
| Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation. | Q46935429 | ||
| Plasminogen potentiates thrombin cytotoxicity and contributes to pathology of intracerebral hemorrhage in rats | Q46947348 | ||
| Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2. | Q47675736 | ||
| Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome. | Q47754161 | ||
| Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats | Q47880020 | ||
| Hyperbaric oxygen preconditioning activates ribosomal protein S6 kinases and reduces brain swelling after intracerebral hemorrhage. | Q47957521 | ||
| Lesion-associated expression of transforming growth factor-beta-2 in the rat nervous system: evidence for down-regulating the phagocytic activity of microglia and macrophages | Q48007027 | ||
| Therapeutic effects of hyperbaric oxygen in a rat model of endothelin-1-induced focal cerebral ischemia | Q48187243 | ||
| Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages | Q48189205 | ||
| Intracerebral hemorrhage after experimental embolic infarction. Anticoagulation | Q48223582 | ||
| Involvement of free radicals in cerebral vascular reperfusion injury evaluated in a transient focal cerebral ischemia model of rat. | Q48226752 | ||
| Inflammation after intracerebral hemorrhage | Q36620460 | ||
| Challenges in the therapeutic use of a "so-called" universal hemostatic agent: recombinant factor VIIa | Q36662271 | ||
| Intracranial hemorrhage associated with revascularization therapies | Q36712045 | ||
| Seminal hemostatic factors: then and now. | Q36718340 | ||
| Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke | Q36721662 | ||
| Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthase | Q37215423 | ||
| Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets | Q37219501 | ||
| Metabolic downregulation: a key to successful neuroprotection? | Q37227909 | ||
| Prostaglandin E2 released from activated microglia enhances astrocyte proliferation in vitro. | Q37235505 | ||
| Clinical application of therapeutic hypothermia in stroke | Q37357335 | ||
| Matrix metalloproteinases and their multiple roles in neurodegenerative diseases | Q37375110 | ||
| Therapeutic hypothermia for acute ischemic stroke | Q37732258 | ||
| First 20 years with recombinant FVIIa (NovoSeven). | Q37770599 | ||
| Exploring Neuroprotective Drug Therapies for Intracerebral Hemorrhage | Q37809948 | ||
| Neuroprotective and neurotrophic curcuminoids to treat stroke: a translational perspective | Q37821005 | ||
| Intracranial hemorrhage: mechanisms of secondary brain injury | Q37897166 | ||
| Tissue destruction by neutrophils | Q38264463 | ||
| Modulation of blood-brain barrier permeability by neutrophils: in vitro and in vivo studies | Q39803965 | ||
| Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies | Q40569474 | ||
| Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia | Q40672673 | ||
| (E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertase | Q40724906 | ||
| Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. | Q40886141 | ||
| Hemoglobin potentiates central nervous system damage | Q40921030 | ||
| Matrix metalloproteinases in brain injury | Q40965342 | ||
| Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis | Q40965397 | ||
| Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate | Q41018029 | ||
| Mechanisms of secondary brain injury | Q41061261 | ||
| Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP. | Q41175511 | ||
| Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor | Q41447978 | ||
| Activation mechanisms of matrix metalloproteinases. | Q41482018 | ||
| Taming TNF: strategies to restrain this proinflammatory cytokine | Q41632994 | ||
| Effect of ganaxolone in a rodent model of cerebral hematoma | Q41712862 | ||
| Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies | Q41744129 | ||
| Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results | Q34164026 | ||
| Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. | Q34170732 | ||
| Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? | Q34171143 | ||
| Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia | Q34171344 | ||
| The science of stroke: mechanisms in search of treatments | Q34212337 | ||
| Protective role of tuftsin fragment 1-3 in an animal model of intracerebral hemorrhage. | Q34274102 | ||
| Metalloproteinases in biology and pathology of the nervous system. | Q34297141 | ||
| The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia | Q34335614 | ||
| Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage. | Q34391036 | ||
| Reducing bleeding complications after thrombolytic therapy for stroke: clinical potential of metalloproteinase inhibitors and spin trap agents | Q34432109 | ||
| Contribution of extracellular proteolysis and microglia to intracerebral hemorrhage | Q34450499 | ||
| Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment | Q34566668 | ||
| Pathophysiology, treatment, and animal and cellular models of human ischemic stroke | Q34569654 | ||
| Protease-activated receptor signaling: new roles and regulatory mechanisms | Q34616653 | ||
| A mouse model of intracerebral hemorrhage using autologous blood infusion | Q34735662 | ||
| Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-alpha production in contact-mediated activation of monocytes by T lymphocytes | Q34735707 | ||
| The development of an improved preclinical mouse model of intracerebral hemorrhage using double infusion of autologous whole blood | Q34789898 | ||
| Matrix metalloproteinases in neuroinflammation | Q34803809 | ||
| Microglia as a source and target of cytokines | Q34963658 | ||
| Neuron protection as a therapeutic target in acute ischemic stroke. | Q35009080 | ||
| Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke Victims | Q35029799 | ||
| Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential | Q35111419 | ||
| Development of the Nitrone‐Based Spin Trap Agent NXY‐059 to Treat Acute Ischemic Stroke | Q35552845 | ||
| The protective effect of early hypothermia on PTEN phosphorylation correlates with free radical inhibition in rat stroke | Q35565926 | ||
| New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies | Q36104043 | ||
| Matrix metalloproteinases and free radicals in cerebral ischemia | Q36144616 | ||
| Interleukin-1 and neuronal injury | Q36202191 | ||
| Protease-activated receptors in hemostasis, thrombosis and vascular biology | Q36230881 | ||
| Potential markers of oxidative stress in stroke. | Q36248257 | ||
| Recent advances in the management of acute intracerebral hemorrhage | Q36303067 | ||
| Controversy of free radical hypothesis: reactive oxygen species--cause or consequence of tissue injury? | Q36322622 | ||
| Mechanisms of brain injury after intracerebral haemorrhage. | Q36345249 | ||
| Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts | Q36351406 | ||
| A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model | Q36485140 | ||
| Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage. | Q48256322 | ||
| Cytokines in brain ischemia--the role of TNF alpha | Q48314443 | ||
| Free radicals as mediators of neuronal injury | Q48314455 | ||
| The increasing incidence of anticoagulant-associated intracerebral hemorrhage | Q48315722 | ||
| Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis of MMP-2, -9 and TIMP-2. | Q48396384 | ||
| Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice. | Q48404400 | ||
| Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage. | Q48491698 | ||
| Systemic zinc protoporphyrin administration reduces intracerebral hemorrhage-induced brain injury. | Q48557199 | ||
| Deferoxamine reduces CSF free iron levels following intracerebral hemorrhage. | Q48557260 | ||
| Delayed profound local brain hypothermia markedly reduces interleukin-1beta gene expression and vasogenic edema development in a porcine model of intracerebral hemorrhage. | Q48557302 | ||
| The influence of hypothermia on outcome after intracerebral hemorrhage in rats. | Q48598668 | ||
| Hyperbaric oxygen suppresses NADPH oxidase in a rat subarachnoid hemorrhage model. | Q48606887 | ||
| Tumor necrosis factor-alpha increases in the brain after intracerebral hemorrhage and thrombin stimulation | Q48622856 | ||
| Attenuation of intracerebral hemorrhage and thrombin-induced brain edema by overexpression of interleukin-1 receptor antagonist | Q48749480 | ||
| Hyperbaric oxygen for experimental intracerebral hemorrhage | Q48809039 | ||
| Early hemorrhage growth in patients with intracerebral hemorrhage | Q48821770 | ||
| Overexpression of copper-zinc superoxide dismutase attenuates acute activation of activator protein-1 after transient focal cerebral ischemia in mice | Q48960143 | ||
| A pilot study of normobaric oxygen therapy in acute ischemic stroke | Q48972485 | ||
| Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures | Q48973809 | ||
| Antisense oligodeoxynucleotide inhibition of tumor necrosis factor-alpha expression is neuroprotective after intracerebral hemorrhage | Q49119558 | ||
| Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome | Q49153559 | ||
| Depressed cortical excitability and elevated matrix metalloproteinases in remote brain regions following intracerebral hemorrhage. | Q51598118 | ||
| Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. | Q53603615 | ||
| Executive Summary: Heart Disease and Stroke Statistics—2010 Update | Q57413935 | ||
| Processing of tumour necrosis factor-α precursor by metalloproteinases | Q59059630 | ||
| Autoradiographic patterns of brain interstitial fluid flow after collagenase-induced haemorrhage in rat | Q67688383 | ||
| Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected] | Q68365170 | ||
| Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits | Q69191650 | ||
| Measurements of acute cerebral infarction: a clinical examination scale | Q69660651 | ||
| Purification and characterization of biliverdin reductase from rat liver | Q70729972 | ||
| Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals | Q70811686 | ||
| Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window | Q71289958 | ||
| Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course | Q71614861 | ||
| Medical therapy for intracerebral hematoma with the gamma-aminobutyric acid-A agonist muscimol | Q73089845 | ||
| Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice | Q73315270 | ||
| Overexpression of interleukin-1 receptor antagonist reduces brain edema induced by intracerebral hemorrhage and thrombin | Q75372808 | ||
| Macrocyclic hydroxamate inhibitors of matrix metalloproteinases and TNF-alpha production | Q77788031 | ||
| MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage | Q79333653 | ||
| Therapeutic hypothermia for acute stroke | Q81789430 | ||
| Mechanisms of Early Brain Injury After SAH: Matrixmetalloproteinase 9 | Q82664202 | ||
| Matrix Metalloproteinase 9 Inhibition Reduces Early Brain Injury in Cortex After Subarachnoid Hemorrhage | Q82664227 | ||
| Effect of normobaric oxygen therapy in a rat model of intracerebral hemorrhage | Q83639307 | ||
| [Hydrogen and oxidative stress injury--from an inert gas to a medical gas] | Q83899434 | ||
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Journal of neurology & neurophysiology | Q27723869 |
| P1476 | title | Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets | |
| P478 | volume | 2011 |
| Q92884386 | Biomarkers of cavernous angioma with symptomatic hemorrhage |
| Q36841904 | Drug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic molecules |
| Q35545189 | Hydrogen improves neurological function through attenuation of blood-brain barrier disruption in spontaneously hypertensive stroke-prone rats |
| Q34114211 | Ligusticum wallichii Extract Inhibited the Expression of IL-1β after AMI in Rats |
| Q34092740 | Transcranial near-infrared laser therapy applied to promote clinical recovery in acute and chronic neurodegenerative diseases. |
Search more.